vs

Side-by-side financial comparison of CuriosityStream Inc. (CURI) and Recon Technology, Ltd (RCON). Click either name above to swap in a different company.

CuriosityStream Inc. is the larger business by last-quarter revenue ($19.2M vs $12.2M, roughly 1.6× Recon Technology, Ltd). Recon Technology, Ltd runs the higher net margin — -6.8% vs -19.7%, a 12.9% gap on every dollar of revenue. On growth, Recon Technology, Ltd posted the faster year-over-year revenue change (111.0% vs 35.8%).

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

Recon Instruments Inc. was a Canadian technology company that produced smartglasses and wearable displays marketed by the company as "heads-up displays" for sports. Recon's products delivered live activity metrics, GPS maps, and notifications directly to the user's eye. Recon's first heads-up display offering was released commercially in October 2010, roughly a year and a half before Google introduced Google Glass.

CURI vs RCON — Head-to-Head

Bigger by revenue
CURI
CURI
1.6× larger
CURI
$19.2M
$12.2M
RCON
Growing faster (revenue YoY)
RCON
RCON
+75.2% gap
RCON
111.0%
35.8%
CURI
Higher net margin
RCON
RCON
12.9% more per $
RCON
-6.8%
-19.7%
CURI

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CURI
CURI
RCON
RCON
Revenue
$19.2M
$12.2M
Net Profit
$-3.8M
$-832.7K
Gross Margin
33.5%
Operating Margin
-17.6%
-14.6%
Net Margin
-19.7%
-6.8%
Revenue YoY
35.8%
111.0%
Net Profit YoY
-34.6%
70.5%
EPS (diluted)
$-0.07
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CURI
CURI
RCON
RCON
Q4 25
$19.2M
$12.2M
Q3 25
$18.4M
Q2 25
$19.0M
Q1 25
$15.1M
Q4 24
$14.1M
$5.8M
Q3 24
$12.6M
Q2 24
$12.4M
Q1 24
$12.0M
Net Profit
CURI
CURI
RCON
RCON
Q4 25
$-3.8M
$-832.7K
Q3 25
$-3.7M
Q2 25
$784.0K
Q1 25
$319.0K
Q4 24
$-2.8M
$-2.8M
Q3 24
$-3.1M
Q2 24
$-2.0M
Q1 24
$-5.0M
Gross Margin
CURI
CURI
RCON
RCON
Q4 25
33.5%
Q3 25
Q2 25
Q1 25
Q4 24
31.7%
Q3 24
Q2 24
Q1 24
Operating Margin
CURI
CURI
RCON
RCON
Q4 25
-17.6%
-14.6%
Q3 25
-24.5%
Q2 25
2.5%
Q1 25
0.5%
Q4 24
-27.4%
-63.9%
Q3 24
-25.8%
Q2 24
-20.6%
Q1 24
-30.4%
Net Margin
CURI
CURI
RCON
RCON
Q4 25
-19.7%
-6.8%
Q3 25
-20.4%
Q2 25
4.1%
Q1 25
2.1%
Q4 24
-19.9%
-48.9%
Q3 24
-24.3%
Q2 24
-16.4%
Q1 24
-42.0%
EPS (diluted)
CURI
CURI
RCON
RCON
Q4 25
$-0.07
$-0.09
Q3 25
$-0.06
Q2 25
$0.01
Q1 25
$0.01
Q4 24
$-0.05
$-0.31
Q3 24
$-0.06
Q2 24
$-0.04
Q1 24
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CURI
CURI
RCON
RCON
Cash + ST InvestmentsLiquidity on hand
$27.3M
$10.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$41.5M
$66.4M
Total Assets
$75.7M
$77.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CURI
CURI
RCON
RCON
Q4 25
$27.3M
$10.7M
Q3 25
$27.8M
Q2 25
$28.1M
Q1 25
$33.4M
Q4 24
$32.1M
$19.9M
Q3 24
$33.2M
Q2 24
$39.5M
Q1 24
$38.8M
Stockholders' Equity
CURI
CURI
RCON
RCON
Q4 25
$41.5M
$66.4M
Q3 25
$47.2M
Q2 25
$49.8M
Q1 25
$58.1M
Q4 24
$57.8M
$66.9M
Q3 24
$62.2M
Q2 24
$64.8M
Q1 24
$67.0M
Total Assets
CURI
CURI
RCON
RCON
Q4 25
$75.7M
$77.6M
Q3 25
$74.7M
Q2 25
$78.7M
Q1 25
$85.3M
Q4 24
$86.2M
$74.2M
Q3 24
$87.6M
Q2 24
$90.9M
Q1 24
$94.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CURI
CURI
RCON
RCON
Operating Cash FlowLast quarter
$4.0M
$-1.9M
Free Cash FlowOCF − Capex
$3.9M
FCF MarginFCF / Revenue
20.5%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CURI
CURI
RCON
RCON
Q4 25
$4.0M
$-1.9M
Q3 25
$4.4M
Q2 25
$2.8M
Q1 25
$1.9M
Q4 24
$3.0M
$-1.7M
Q3 24
$2.3M
Q2 24
$2.2M
Q1 24
$666.0K
Free Cash Flow
CURI
CURI
RCON
RCON
Q4 25
$3.9M
Q3 25
Q2 25
Q1 25
$1.8M
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
CURI
CURI
RCON
RCON
Q4 25
20.5%
Q3 25
Q2 25
Q1 25
12.2%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
CURI
CURI
RCON
RCON
Q4 25
0.1%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.5%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
CURI
CURI
RCON
RCON
Q4 25
Q3 25
Q2 25
3.56×
Q1 25
6.03×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons